Publications by authors named "Richard D O'Connor"

Claim this Profile
U
Use of ICS/LABA on Asthma Exacerbation Risk in Patients Within a Medical Group.
Richard H Stanford, Saurabh Nagar, Xiwu Lin, Richard D O'Connor

J Manag Care Spec Pharm· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with budesonide/formoterol pressurized metered-dose inhaler in patients with asthma: a focus on patient-reported outcomes.
Richard D O'Connor

Patient Relat Outcome Meas· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subacute lack of asthma control and acute asthma exacerbation history as predictors of subsequent acute asthma exacerbations: evidence from managed care data.
Richard D O'Connor, Eugene R Bleecker, Aidan Long, Donald Tashkin, Stephen Peters

J Asthma· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
Richard D O'Connor, Donald L Patrick, Bhash Parasuraman, Paula Martin, Mitchell Goldman

J Asthma· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhaled corticosteroids vs leukotriene receptor antagonists: health care costs across varying asthma severities.
Richard D O'Connor, Bhash Parasuraman, Craig Roberts, Christopher Leibman

Ann Allergy Asthma Immunol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing outcomes in patients with persistent asthma: a registry of two therapeutic alternatives.
Richard D O'Connor, Amanda S Gilmore, Ranjani Manjunath, Richard H Stanford, Antonio P Legorreta

Curr Med Res Opin· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asthma-related exacerbations, therapy switching, and therapy discontinuation: a comparison of 3 commonly used controller regimens.
Richard D O'Connor, Jacqueline R Carranza Rosenzweig, Richard H Stanford, Amanda S Gilmore, Kira L Ryskina

Ann Allergy Asthma Immunol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costs.
Richard D O'Connor, Richard Stanford, Courtney Crim, Steven W Yancey, Lisa Edwards

Ann Allergy Asthma Immunol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
Richard D O'Connor, Harold Nelson, Rohit Borker, Amanda Emmett, Priti Jhingran

Pharmacoeconomics· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of allergic disease among users of antihistamines.
Sheryl L Szeinbach, Brock Williams, Pieter Muntendam, Richard D O'Connor

J Manag Care Pharm· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underestimating asthma severity--variability of classifications and outcomes.
Richard D O'Connor

Manag Care· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current approaches to asthma management: assessing clinical and economic evidence.
Richard D O'Connor

J Manag Care Pharm· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Setting the gold standard: clinical and economic decision making in asthma management.
Richard D O'Connor

Manag Care· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year retrospective economic evaluation of three dual-controller therapies used in the treatment of asthma.
Richard D O'Connor, John C O'Donnell, Lionel A Pinto, Douglas J Wiener, Antonio P Legorreta

Chest· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relation between tumour necrosis factor polymorphism TNFalpha-308 and risk of asthma.
John S Witte, Lyle J Palmer, Richard D O'Connor, Penelope J Hopkins, Jeff M Hall

Eur J Hum Genet· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis